首页 | 本学科首页   官方微博 | 高级检索  
检索        

小核非编码RNA 7SK 128-179截短体通过下调CDC6抑制胚胎干细胞的体外增殖
引用本文:陈 蕊,张玉荣,陈 鹏,庞依心,李宏宝,陈子溦,张小用,张鸿毅,李武军.小核非编码RNA 7SK 128-179截短体通过下调CDC6抑制胚胎干细胞的体外增殖[J].南方医科大学学报,2021,41(8):1125-1130.
作者姓名:陈 蕊  张玉荣  陈 鹏  庞依心  李宏宝  陈子溦  张小用  张鸿毅  李武军
作者单位:西安医学院第一附属医院,陕西 西安 710077;西安医学院基础医学部,陕西西安710021;西安交通大学第二附属医院,陕西 西安 710004;西安交通大学基础医学部生理与病理生理学系,陕西 西安 710061;西安医学院临床医学院,陕西 西安 710021
摘    要:目的 探讨小核非编码RNA 7SK在胚胎干细胞(ESCs)增殖中的作用,为原始侏儒症疾病的早期诊治提供靶点。方法 利用CRISPR/Cas9系统转染ESCs,通过PCR产物测序和甘油梯度分析鉴定每个单克隆细胞系获得7SK 128-179 突变体。使用慢病毒系统敲除CDK9,然后通过Western blotting分析敲除效率和相关通路蛋白的变化。结果 CRISPR/Cas9系统转染后,ESCs中出现128-179 nt缺失突变的7SK,该突变导致ESCs增殖缺陷。7SK 128-179 nt突变的ESCs中LARP7和CDC6的蛋白水平显著下调,通过干预CDK9的活性发现7SK对ESCs增殖的调控作用依赖于CDK9的活性。结论 7SK 128-179 nt截短体可通过下调 CDC6 严重影响ESCs的增殖,且这一过程依赖于CDK9活性,提示7SK截短突变可作为侏儒症的早期筛查和治疗靶点。

关 键 词:7SK截短体  胚胎干细胞  增殖  周期蛋白依赖激酶9  细胞分裂周期蛋白6

7SK truncation at 128-179 nt suppresses embryonic stem cell proliferation in vitro by downregulating CDC6
CHEN Rui,ZHANG Yurong,CHEN Peng,PANG Yixin,LI Hongbao,CHEN Ziwei,ZHANG Xiaoyong,ZHANG Hongyi,LI Wujun.7SK truncation at 128-179 nt suppresses embryonic stem cell proliferation in vitro by downregulating CDC6[J].Journal of Southern Medical University,2021,41(8):1125-1130.
Authors:CHEN Rui  ZHANG Yurong  CHEN Peng  PANG Yixin  LI Hongbao  CHEN Ziwei  ZHANG Xiaoyong  ZHANG Hongyi  LI Wujun
Institution:First Affiliated Hospital of Xi'an Medical University, Xi'an 710077, China; Institute of Basic Medical Science, Xi'an Medical University, Xi'an 710021, China; Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China; Department of Physiology and Pathophysiology, Xi'an Jiaotong University School of Basic Medical Sciences, Xi'an 710061, China; School of Clinical Medicine, Xi'an Medical University, Xi'an 710021, China
Abstract:Objective To explore the role of small nuclear noncoding RNA 7SK in embryonic stem cell (ESCs) proliferation and the value of 7SK as a target for early diagnosis and treatment for primordial dwarfism (PD). Methods ESC line R1 was transfected with the CRISPR/Cas9 system, and sequencing of the PCR product and glycerol gradient analysis were performed to identify novel 7SK deletion mutations. A lentivirus system was used to knock down cyclin-dependent kinase 9 (CDK9) in clones with 7SK deletion mutations, and the effect of CDK9 knockdown on the protein level of cell division cycle 6 (CDC6) was analyzed with Western blotting. Results We identified a novel deletion mutation of 7SK at 128-179 nt in the ESCs, which resulted in deficiency of cell proliferation. 7SK truncation at 128-179 nt significantly reduced the protein expressions of La-related protein 7 (LARP7) and CDC6. Conclusions 7SK truncation at 128-179 nt can significantly impair proliferation of ESCs by downregulating CDC6. 7SK is a key regulator of proliferation and mediates the growth of ESCs through a mechanism dependent on CDK9 activity, suggesting the value of 7SK truncation at 128-179 nt as a potential target for early diagnosis and treatment of PD.
Keywords:7SK truncation  embryonic stem cell  proliferation  cyclin-dependent kinase 9  cell division cycle 6  
本文献已被 万方数据 等数据库收录!
点击此处可从《南方医科大学学报》浏览原始摘要信息
点击此处可从《南方医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号